Trial
NCT05764265
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Pulmonary Arterial Hypertension
Intervention
LTP001
Why stopped
Sponsor Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-27